Bromfenac Solution/ Drops
Product Images NDC 49708-755

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bromfenac (NDC 49708-755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-bromfenac-bottle-label (Spl Bromfenac Bottle Label)

Spl-bromfenac-bottle-label (Spl Bromfenac Bottle Label)
Label for bromfenac ophthalmic solution 0.075%, a sterile 5 mL prescription eye drop. The label states the active ingredient bromfenac sodium sesquihydrate equivalent to bromfenac free acid 0.76 mg/mL. It includes the NDC 49708-755-41 and is labeled by Sun Pharmaceutical Industries, Inc.*
FDA Label Image

Spl-bromfenac-carton-label (Spl Bromfenac Carton Label)

Spl-bromfenac-carton-label (Spl Bromfenac Carton Label)
Packaging label for Bromfenac Ophthalmic Solution 0.075% sterile drops. The label states a 5 mL volume with prescription-only use, distributed by Sun Pharmaceutical Industries, Inc. It includes instructions for topical ophthalmic use, active ingredient concentration (.76 mg/mL bromfenac), storage conditions, and a list of inactive ingredients and preservative. The design features the SUN Pharma logo and multiple barcodes.*
FDA Label Image

Spl-bromfenac-fig A (Spl Bromfenac Fig A)

Spl-bromfenac-fig A (Spl Bromfenac Fig A)
An instructional diagram labeled Figure A, showing a hand holding an ophthalmic drop bottle inverted above an open palm, illustrating the method of dispensing eye drops from the bottle.*
FDA Label Image

Spl-bromfenac-fig B (Spl Bromfenac Fig B)

Spl-bromfenac-fig B (Spl Bromfenac Fig B)
Illustration showing how to open a bottle by twisting the cap. The image depicts a hand turning the cap to unlock and remove it, commonly found in instructions for using ophthalmic solution bottles such as bromfenac 0.075% ophthalmic drops.*
FDA Label Image

Spl-bromfenac-fig C (Spl Bromfenac Fig C)

Spl-bromfenac-fig C (Spl Bromfenac Fig C)
An instructional illustration labeled 'Figure C' showing a hand holding a small dropper bottle upside down above the palm, demonstrating how to administer ophthalmic solution drops.*
FDA Label Image

Spl-bromfenac-fig D (Spl Bromfenac Fig D)

Spl-bromfenac-fig D (Spl Bromfenac Fig D)
Illustration showing hand positioning for administering ophthalmic solution or drops. One hand holds a bottle above the open palm of the opposite hand, with an arrow indicating a motion or direction related to applying or dispensing the drops.*
FDA Label Image

Spl-bromfenac-fig E (Spl Bromfenac Fig E)

Spl-bromfenac-fig E (Spl Bromfenac Fig E)
An instructional illustration showing a hand holding an ophthalmic dropper bottle above the other hand, demonstrating the method to instill eye drops from the bottle. The image depicts the correct positioning of the dropper for administration.*
FDA Label Image

Spl-bromfenac-fig F (Spl Bromfenac Fig F)

Spl-bromfenac-fig F (Spl Bromfenac Fig F)
Instructional diagram showing administration of ophthalmic solution where drops are applied into an eye by tilting the head back. The illustration depicts a hand holding a dropper above a person's open eye.*
FDA Label Image

Spl-bromfenac-foil-label (Spl Bromfenac Foil Label)

Spl-bromfenac-foil-label (Spl Bromfenac Foil Label)
Packaging label for bromfenac 0.075% ophthalmic solution, 5 mL, a human prescription drug by Sun Pharmaceutical Industries, Inc. The label includes repeated text of the product name and strength, along with a barcode and folding instructions on a light pink background.*
FDA Label Image

Spl-bromfenac-str (Spl Bromfenac Str)

Spl-bromfenac-str (Spl Bromfenac Str)
Chemical structure diagram of bromfenac showing its molecular framework including a bromine-substituted aromatic ring, amine group, sodium carboxylate, and a hydrate component (1.5 water molecules).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.